Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy

L. Bartalena; G. E. Krassas; W. Wiersinga; C. Marcocci; M. Salvi; C. Daumerie; C. Bournaud; M. Stahl; L. Sassi; G. Veronesi; C. Azzolini; K. G. Boboridis; M. P. Mourits; M. R. Soeters; L. Baldeschi; M. Nardi; N. Currò; A. Boschi; M. Bernard; G. von Arx

首页> 外文期刊>The journal of clinical endocrinology and metabolism >Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy

【24h】

Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy

机译：三种不同剂量的静脉注射甲基强的松龙对中度和重度活动性格雷夫斯眼病的疗效和安全性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:Optimal doses of iv glucocorticoids for Graves' orbitopathy (GO) are undefined.

机译：背景：尚未确定格雷夫斯眼病（GO）的iv糖皮质激素的最佳剂量。

著录项

来源
《The journal of clinical endocrinology and metabolism》 |2012年第12期|共10页
作者
L. Bartalena; G. E. Krassas; W. Wiersinga; C. Marcocci; M. Salvi; C. Daumerie; C. Bournaud; M. Stahl; L. Sassi; G. Veronesi; C. Azzolini; K. G. Boboridis; M. P. Mourits; M. R. Soeters; L. Baldeschi; M. Nardi; N. Currò; A. Boschi; M. Bernard; G. von Arx;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves’ orbitopathy: A randomized controlled trial [J] . Ajitesh Roy, Deep Dutta, Sujoy Ghosh, Indian Journal of Endocrinology and Metabolism . 2015,第3期

机译：低剂量口服泼尼松龙与脉冲静脉注射甲基泼尼松龙在中度重度Graves眼病治疗中的疗效和安全性：一项随机对照试验
2. Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy [J] . Yoriko Ueda-Sakane, Naotetsu Kanamoto, Yasutaka Fushimi, Endocrine journal . 2016,第8期

机译：大剂量和小剂量静脉糖皮质激素治疗对中度至重度活动性Graves眼病患者的总体安全性和有效性
3. Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves’ ophthalmopathy [J] . Akihiro Yasoda, Kaori Togashi, Kazuwa Nakao, Endocrine journal . 2016,第8期

机译：大剂量和小剂量静脉糖皮质激素治疗对中度至重度活动性Graves眼病患者的总体安全性和有效性
4. Therapy of Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Efficacy, Tolerability, and Safety of a New Nanofiltered Intravenous Immunoglobulin [C] . H.-H. Wolf, S. Davies, G. Smith, European Haematology Association . 2002

机译：慢性免疫血小板减少症患者的治疗患者（ITP）：一种新的纳米过滤静脉内免疫球蛋白的疗效，耐受性和安全性
5. Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer's Disease in a Long Term Care Setting. [D] . O'Regan, Jordana. 2014

机译：在长期护理环境中评估中度至重度阿尔茨海默氏病患者停用胆碱酯酶抑制剂的安全性。
6. Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves Orbitopathy [O] . Miaoli Lin, Yuxiang Mao, Siming Ai, 2015

机译：亚抗微生物剂量强力霉素对中度至重度和活动性Graves眼病的疗效
7. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. [O] . Bartalena L, Krassas GE, Wiersinga W, 2012

机译：三种不同累积剂量静脉注射甲基强的松龙对中度至重度和活动性格雷夫斯眼病的疗效和安全性。

Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy

摘要

著录项

相似文献

相关主题

期刊订阅